Joanna Matysiak
University of Life Sciences in Lublin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joanna Matysiak.
Archiv Der Pharmazie | 2011
Andrzej Niewiadomy; Joanna Matysiak; Monika M. Karpińska
New compounds of 2‐aryl‐4H‐3,1‐benzothiazine set were synthesized and tested for their antiproliferative activity as part of our research in the antitumor field. The title compounds were obtained by the reaction of aryl‐modified sulfinylbis((2,4‐dihydroxyphenyl)methanethione) with 2‐aminobenzyl alcohols. The reaction proceeded through thiobenzanilide intermediates, which were converted to the 4H‐3,1‐benzothiazine fused ring by an endocyclization process. The structures of compounds were identified from elemental, IR, 1H‐NMR, 13C‐NMR, and MS spectra analyses. The cytotoxicity in vitro against four human cancer cell lines was determined. The antiproliferative properties of some compounds were more beneficial than cisplatin studied comparatively.
Archiv Der Pharmazie | 2012
Joanna Matysiak; Renata Los; Anna Malm; Monika M. Karpińska; Urszula Głaszcz; Barbara Rajtar; Małgorzata Polz-Dacewicz; Marta Trojanowska-Wesołowska; Andrzej Niewiadomy
In an attempt to find a new class of antimicrobial agents, a series of benzothiazoles, 1,3‐thiazolo[5,4‐b]pyridines, 4H‐3,1‐benzothiazines, naphtho[2,3‐d][1,3]thiazole‐4,9‐diones and other related compounds containing a 2,4‐dihydroxyphenyl moiety were prepared. They were obtained via the reaction of aryl‐modified sulfinyl[bis(2,4‐dihydroxyphenylmethanethione)]s with appropriate commercial chemical reagents in the endocyclization processes. The MIC values of the compounds towards eight reference bacterial strains were assessed by the two‐fold serial micro‐dilution broth method. They exhibited inhibitory effects against the Gram‐positive strains tested opposite to Gram‐negative ones. Some compounds were more effective than the reference drug. 4‐(6‐Chloro‐4H‐3,1‐benzothiazin‐2‐yl)‐6‐methylbenzene‐1,3‐diol (5b) due to its very good activity (MIC from 1.56 to 3.13u2009µg/mL) and low cytotoxicity (IC50u2009>u200950u2009µg/mL) may be regarded as a promising precursor for the development of novel antibacterial agents.
Molecular Diversity | 2015
Joanna Matysiak; Małgorzata Juszczak; Monika M. Karpińska; Ewa Langner; Katarzyna Walczak; Marta Kinga Lemieszek; Alicja Skrzypek; Andrzej Niewiadomy; Wojciech Rzeski
A new one-step synthesis of novel biologically active 2-substituted 2,4-dihydroxyphenyl-4
Pharmacological Reports | 2015
Jarogniew J. Luszczki; Monika M. Karpińska; Joanna Matysiak; Andrzej Niewiadomy
Monatshefte Fur Chemie | 2012
Monika M. Karpińska; Joanna Matysiak; Andrzej Niewiadomy; Joanna Wietrzyk; Dagmara Klopotowska
H
Monatshefte Fur Chemie | 2015
Joanna Matysiak; Małgorzata Juszczak; Monika M. Karpińska; Ewa Langner; Katarzyna Walczak; Marta Kinga Lemieszek; Alicja Skrzypek; Wojciech Rzeski; Andrzej Niewiadomy
Molecular Diversity | 2017
Joanna Matysiak; Andrzej Niewiadomy
H-thieno[3,2-
Monatshefte Fur Chemie | 2012
Monika Pitucha; Joanna Matysiak; Bogdan Senczyna
Russian Journal of Bioorganic Chemistry | 2016
Joanna Matysiak; Alicja Skrzypek; Andrzej Niewiadomy; Monika M. Karpińska; Joanna Wietrzyk; Beata Paw; Dagmara Klopotowska
d
Research on Chemical Intermediates | 2018
Joanna Matysiak; Alicja Skrzypek; Urszula Głaszcz; Arkadiusz Matwijczuk; Bogdan Senczyna; Joanna Wietrzyk; Elżbieta Krajewska-Kułak; Andrzej Niewiadomy